Full history for every metric is available with a Kvantra account

Stock profile
Quest Diagnostics Incorporated logo

Quest Diagnostics Incorporated (DGX)

Country: United States of AmericaSector: HealthcareIndustry: Medical - Diagnostics & ResearchExchange: NYSE
P/E TTM
25.7
History
P/E NTM
21.7
Market cap
28.42B
Currency USD
KvantraRankAbout61
IValue66
IIQuality58
IIIMomentum58
Current price
258.28 USD-0.31%
Close 20 Nov 2026
Interval
Benchmarks

Key financial summary

Financials in USD
202020212022202320242025TTM2026E
Total revenue$bn9.410.89.99.39.911.011.812.1
Operating profit$bn1.601.72
Net profit$bn1.432.000.950.850.870.991.131.28
EPS reported$8.7510.04
Operating cashflow per share$16.9917.74
Capex per share$4.755.24
FCF per share$12.2412.50
Free cash flow$bn1.361.38
Net debt$bn6.505.49
Book value equity$bn7.177.63
Book value per share$63.4568.14
Number of sharesm113112
DPS (TTM paid)$3.153.38

Financial summary

Financials in USD
202020212022202320242025TTM2026E
Value
P/E TTMx19.8325.73
P/B LTMx2.693.72
P/S LTMx1.752.40
P/FCF LTMx14.1720.67
EV/EBITDA LTMx11.7414.89
EV/Sales LTMx2.332.90
Earnings Yield LTM%5.04%3.89%
FCF Yield%7.06%4.84%
Quality
ROE%13.84%15.21%
ROIC%8.18%8.54%
Operating margin%14.10%14.55%
Gross margin%33.21%33.11%
FCF/Sales%12.32%11.61%
Growth and momentum
EPS Growth YoY%+13.78%+17.84%
Sales Growth YoY%+11.78%+9.13%
Net Income Growth YoY%+13.89%+16.51%
FCF Growth%+49.50%-1.29%
Operating Profit Growth%+19.09%+12.54%
Dividend and capital structure
Dividend Yield%1.83%1.31%
Dividend Growth%+6.42%+7.30%
Payout Ratio%35.70%32.82%
FCF/Debtx0.200.22
Net Debt/EBITDAx2.962.38
EBIT/Net interestx5.626.78
Net debt/market cap%33.74%19.31%
Net debt/Equityx0.910.72
Gross debt/equityx0.960.82

ETFs that hold Quest Diagnostics

FundTickerPosition#Weight
iShares U.S. Healthcare Providers ETFIHF103.48%
John Hancock Exchange Traded Fund Trust - John Hancock Discipline Value Select ETFJDVL102.82%
M.D. Sass Concentrated Value ETFSASS55.18%
UBS Factor MSCI USA Low Volatility UCITS ETF USD disUBUR.DE71.06%

Funds with Quest Diagnostics among their ten largest holdings, largest fund first.

Price target estimates

Low estimate
High estimate
Price consensus
Last year average price target
Current price258.28 USD
Return Potential

Based on consensus from external analysts. Not Kvantra's opinion.

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

ESG

Metric202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating

Company overview

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Quest Diagnostics Incorporated (DGX)

DGX · NYSE · Healthcare
258.28 USD-0.31%
Sign up to track this stock
Benchmarks
KvantraRank61
Market cap28.42B
P/E NTM21.7
P/E TTM25.7
KvantraRank?61 / 100
Value
66
Quality
58
Momentum
58
Financialsin USD
20242025TTM2026E
ETFs that hold Quest Diagnostics
FundTickerPosition#Weight
iShares U.S. Healthcare Providers ETFIHF103.48%
John Hancock Exchange Traded Fund Trust - John Hancock Discipline Value Select ETFJDVL102.82%
M.D. Sass Concentrated Value ETFSASS55.18%
UBS Factor MSCI USA Low Volatility UCITS ETF USD disUBUR.DE71.06%

Funds with Quest Diagnostics among their ten largest holdings, largest fund first.

Analyst target
Consensus
Current258.28 USD
Upside
Price consensus
Last year average price target
Current price258.28 USD
Return Potential

Consensus from external analysts. Not Kvantra's opinion.

Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

ESG
202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating
About

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

IndustryMedical - Diagnostics & Research
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free